30 Nov 2020
CureVac and WACKER sign contract to manufacture COVID-19 vaccine candidate
By Staff Writer
WACKER Chemie has signed a contract with biopharmaceutical company, CureVac, for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV. Under the terms of the initial agreement, WACKER will ramp up GMP (Good Manufacturing Practice) production of the mRNA drug substance for CVnCoV at its biotech site in Amsterdam in the first half of 2021. Preparations...
